logo

ASPI

ASP Isotopes·NASDAQ
--
--(--)
--
--(--)

ASPI fundamentals

ASP Isotopes (ASPI) released its earnings on Nov 19, 2025: revenue was 4.90M (YoY +345.45%), met estimates; EPS was -0.15 (YoY -66.67%), met estimates.
Revenue / YoY
4.90M
+345.45%
EPS / YoY
-0.15
-66.67%
Report date
Nov 19, 2025
ASPI Earnings Call Summary for Q3,2025
  • Operational Momentum: Silicon-28 customer validation and ytterbium-176 production ramp-up highlight commercial traction. QLE's KUBE unit and Supercritical Technologies expand nuclear fuel supply chain dominance.
  • Financial Growth: Radiopharmaceutical revenue up 24% YoY, offsetting high R&D expenses. $200M post-quarter capital raise supports plant expansion.
  • Strategic Acquisitions: Supercritical Technologies and Renergen acquisition position QLE as end-to-end nuclear fuel supplier. Skyline divestiture focuses on critical materials.
  • Key Milestones: Phase 1C completion by end-Q1 2026, first carbon-12 shipments in December, and HALEU production in South Africa.
EPS
Q4,undefined
Q1,undefined
Q2,undefined
Q4,undefined
Q1,undefined
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
-0.24-0.09-0.13-0.12-1.03-0.15
Forecast
-0.09-0.09-0.12-1.03-0.15
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-44.44%
0.00%
0.00%
0.00%
Revenue
Q4,undefined
Q1,undefined
Q2,undefined
Q4,undefined
Q1,undefined
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
----------1.00M1.10M1.20M1.10M1.20M4.90M
Forecast
------------1.10M1.20M1.05M1.20M4.90M
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+4.66%
0.00%
0.00%

Earnings Call